- Home
- FEMY vs IRIX Comparison
FEMY vs IRIX Comparison
Compare FEMY & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- IRIX
- Stock Information
- Founded
- FEMY 2004
- IRIX 1989
- Country
- FEMY United States
- IRIX United States
- Employees
- FEMY N/A
- IRIX N/A
- Industry
- FEMY Medical/Dental Instruments
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FEMY Health Care
- IRIX Health Care
- Exchange
- FEMY Nasdaq
- IRIX Nasdaq
- Market Cap
- FEMY 27.2M
- IRIX 28.6M
- IPO Year
- FEMY 2021
- IRIX 1996
- Fundamental
- Price
- FEMY $1.09
- IRIX $1.64
- Analyst Decision
- FEMY Strong Buy
- IRIX Hold
- Analyst Count
- FEMY 3
- IRIX 1
- Target Price
- FEMY $10.00
- IRIX $2.00
- AVG Volume (30 Days)
- FEMY 185.8K
- IRIX 29.8K
- Earning Date
- FEMY 11-12-2024
- IRIX 11-12-2024
- Dividend Yield
- FEMY N/A
- IRIX N/A
- EPS Growth
- FEMY N/A
- IRIX N/A
- EPS
- FEMY N/A
- IRIX N/A
- Revenue
- FEMY $1,260,643.00
- IRIX $48,431,000.00
- Revenue This Year
- FEMY $157.75
- IRIX N/A
- Revenue Next Year
- FEMY $254.07
- IRIX $5.44
- P/E Ratio
- FEMY N/A
- IRIX N/A
- Revenue Growth
- FEMY 15.33
- IRIX N/A
- 52 Week Low
- FEMY $0.73
- IRIX $1.27
- 52 Week High
- FEMY $2.40
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- FEMY 46.31
- IRIX 43.85
- Support Level
- FEMY $1.05
- IRIX $1.61
- Resistance Level
- FEMY $1.24
- IRIX $1.89
- Average True Range (ATR)
- FEMY 0.08
- IRIX 0.10
- MACD
- FEMY -0.00
- IRIX -0.02
- Stochastic Oscillator
- FEMY 16.00
- IRIX 8.82
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.